Market capitalization | €939.88m |
Enterprise Value | €1.02b |
PER (TTM) P/E ratio | 9.35 |
EV/FCF (TTM) EV/FCF | 6.00 |
EV/Sales (TTM) EV/Sales | 0.30 |
P/S ratio (TTM) P/S ratio | 0.28 |
P/B ratio (TTM) P/B ratio | 0.66 |
Dividend yield | 3.59% |
Last dividend (FY23) | €1.80 |
As a Free StocksGuide user, you can view scores for all 6,945 stocks worldwide.
5 Analysts have issued a Drägerwerk forecast:
5 Analysts have issued a Drägerwerk forecast:
Mar '24 |
+/-
%
|
||
Revenue | 736 736 |
5%
5%
|
|
Gross Profit | 334 334 |
3%
3%
|
|
EBITDA | 48 48 |
22%
22%
|
EBIT (Operating Income) EBIT | 15 15 |
17%
17%
|
Net Profit | 7.08 7.08 |
38%
38%
|
In millions EUR.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Drägerwerk AG & Co. KGaA engages in the provision of medical and safety technology products. It operates through the following geographical segments: Europe; Americas; and Africa, Asia, and Austria (AAA). The company was founded by Johann Heinrich Draeger in 1889 and is headquartered in Luebeck, Germany.
Head office | Germany |
CEO | Stefan Dräger |
Employees | 16,329 |
Founded | 1889 |
Website | www.draeger.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.